Pharmaceuticals News and Research

RSS

Novozymes Biopharma partners with Almac to provide combined service for drug development

Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, is delighted to announce its new collaboration with Almac, to provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic improvements.

22 Oct 2013

Sanofi uses QUOSA's literature management tools to automate adverse event monitoring

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that Sanofi, one of the world's leading pharmaceutical organizations, has implemented QUOSA's literature management tools to automate adverse event monitoring.

22 Oct 2013

Pfizer to continue development of Remoxy Extended-Release Capsules CII

Pfizer Inc. announced today that, having achieved technical milestones related to manufacturing, it will continue the development program for Remoxy (oxycodone) Extended-Release Capsules CII.

22 Oct 2013

InnoCore, Allergan expand collaboration to develop ophthalmology medicines

InnoCore Pharmaceuticals today announced that it has signed an exclusive License and Collaboration Agreement with Allergan, Inc., a multi-specialty health care company headquartered in Irvine, California.

22 Oct 2013

Capsugel launches Coni-Snap sprinkle capsule for people with difficulties swallowing

Capsugel is launching an innovative capsule design to improve adherence to treatment regimens for patients with difficulties swallowing. These patients include babies, children, and older adults as well as patients with medical conditions such as Alzheimer's, Parkinson's, and Multiple Sclerosis. The new Coni-Snap sprinkle capsule is expected to be available in 2014.

22 Oct 2013

Pancreatic cancer patients may benefit from antibody-drug conjugates

Patients with pancreatic cancer may benefit from an investigational member of an emerging class of anticancer drugs called antibody-drug conjugates, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

22 Oct 2013

Univar signs agreement with Swati Spentose to become exclusive distributor of Lidocaine products

Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.

22 Oct 2013

SPARC announces award recipients for Accelerating Science Award Program

The three award recipients for the Accelerating Science Award Program (ASAP) were announced today in Washington, DC at the Open Access Week kickoff event hosted by the Scholarly Publishing and Academic Resources Coalition (SPARC) and the World Bank.

22 Oct 2013

Dietary change should be considered in chronic prostatitis

Researchers from the USA say that physicians should consider dietary changes for patients with chronic prostatitis/chronic pelvic pain syndrome to improve symptoms.

21 Oct 2013

Astrazeneca, Evotec Launch Kidney Disease Collaboration

...

21 Oct 2013

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Cubist Pharmaceuticals, Inc. today announced the approval of its supplemental new drug application (sNDA) by the U.S. Food and Drug Administration for ENTEREG (alvimopan).

21 Oct 2013

Research paper published by Scientific Reports details the efficacy of n3D's Apple iPhone app

Joint venture partners Rainbow Coral Corp. and Nano3D Biosciences (n3D) are proud to announce that the journal Scientific Reports published the first research document detailing the efficacy of n3D's revolutionary new Apple iPhone app today.

21 Oct 2013

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

Regeneron Pharmaceuticals, Inc. today announced positive topline results for EYLEA® (aflibercept) Injection from the Phase 3 VIBRANT study in patients with Macular Edema following Branch Retinal Vein Occlusion (BRVO).

21 Oct 2013

DOH releases SPHHS study investigating prescribing of antipsychotics to District seniors

The District of Columbia Department of Health has released a study by the George Washington University School of Public Health and Health Services investigating prescribing of antipsychotics to District seniors.

21 Oct 2013

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced today the presentation of preclinical data from a study to assess the role of p53 family tumor suppressors in mediating response to ENMD-2076 in triple-negative breast cancer (TNBC).

21 Oct 2013

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat® inhaler. It is being investigated as a once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

21 Oct 2013

ChromaDex gets equity financing from DSM Venturing

ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.

21 Oct 2013

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Inovio Pharmaceuticals, Inc. announced today that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients.

21 Oct 2013

DrugDev acquires CFS Clinical

DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced today its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.

21 Oct 2013

Breast milk purchased over Internet contained bacteria that can cause illness in infants

Results from a study led by researchers at Nationwide Children's Hospital found more than three-fourths of breast milk samples purchased over the Internet contained bacteria that can cause illness, and frequently exhibited signs of poor collection, storage or shipping practices.

21 Oct 2013

Pharmaceuticals News and Research

Novozymes Biopharma partners with Almac to provide combined service for drug development

Sanofi uses QUOSA's literature management tools to automate adverse event monitoring

Pfizer to continue development of Remoxy Extended-Release Capsules CII

InnoCore, Allergan expand collaboration to develop ophthalmology medicines

Capsugel launches Coni-Snap sprinkle capsule for people with difficulties swallowing

Pancreatic cancer patients may benefit from antibody-drug conjugates

Univar signs agreement with Swati Spentose to become exclusive distributor of Lidocaine products

SPARC announces award recipients for Accelerating Science Award Program

Dietary change should be considered in chronic prostatitis

Astrazeneca, Evotec Launch Kidney Disease Collaboration

FDA approves Cubist Pharmaceuticals' sNDA for ENTEREG

Research paper published by Scientific Reports details the efficacy of n3D's Apple iPhone app

Regeneron announces topline results from Phase 3 study of EYLEA Injection in patients with Macular Edema following BRVO

DOH releases SPHHS study investigating prescribing of antipsychotics to District seniors

EntreMed presents preclinical data for ENMD-2076 in triple-negative breast cancer

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

ChromaDex gets equity financing from DSM Venturing

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

DrugDev acquires CFS Clinical

Breast milk purchased over Internet contained bacteria that can cause illness in infants

A guide to density measurement excellence eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence